-

                               
 
 APPROACHES IN PHARMACOVIGILANCE

The importance of pharmacovigilance the ongoing assessment of the safety of a marketed medicine has been increasingly appreciated in recent years, owing in part to high-profile safety issues with widely used drugs. In response, strategies to improve the collection, integration and analysis of data related to post-marketing drug safety are being initiated or enhanced. The key tools that are available for pharmacovigilance are appropriate to use in different situations and consider the future directions of the field.
Study designs used in pharmacovigilance
Case reports and case series:  Case reports are concerned with single patients who have been exposed to a drug and experienced an adverse reaction. Case series can refer to a collection of patients who have been exposed to the same drug and whose clinical outcomes are then evaluated and described. Alternatively, a case series can be a collection of patients with a single outcome, whose history is then checked to ascertain previous drug exposure.
Case-control studies:  Case-control studies are retrospective studies where a group of patients with a particular disease (or ADR) are compared with a group of patients who do not have the disease, and their histories of previous exposure to a "risk factor" are compared. They can be used to study multiple drug exposures, uncommon diseases. They are relatively easy, fast and cheap in terms of data collection. However, case control studies also have their weaknesses i.e. Finding appropriate matched controls may be difficult.
Cohort studies: Cohort studies compare a group of individuals with a drug exposure to a group without the same exposure in terms of adverse outcomes. The study can be either prospective or retrospective. They allow calculation of incidence rates and precise risks and can be used to study multiple outcomes providing unbiased drug exposure data with selection bias less than in case-control studies. Their weaknesses are that they are relatively more expensive, especially the ad hoc studies.
Meta-analyses: In this era of evidence-based medicine, meta-analyses allow investigators to review clinical trial data systematically. Although most investigators are interested in the efficacy of treatments, it is also possible to investigate adverse outcomes systematically. A systematic review of randomized controlled trials involving administration of human albumin in critically ill patients has been undertaken.
Until recently, pharmacovigilance was mainly based on spontaneous reports, which provide low evidence of risks associated with medicines. Today, the importance of the full spectrum of the evidence hierarchy is recognized. This article reviews new approaches and data sources used in pharmacovigilance and shows that individual case safety reports, observational data, clinical trials and meta-analyses have unique characteristics that complement each other for the overall benefit–risk evaluation of medicines
In the past two decades, pharmacovigilance scientists have increasingly adopted the fundamentals of epidemiological research and applied them to the study of drugs. These techniques give us better understanding of the beneficial and adverse outcomes of medicines use. No doubt they will continue to play important roles in pharmacovigilance.


For more details join us @ https://drug-chemistry.pharmaceuticalconferences.com/



Comments

Post a Comment

Popular posts from this blog

Nanomedicine & Women’s Health

-
Image
Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health Nanomedicine is the application of  nanotechnology  in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an increasing rol
Read more

20th World Conference on Pharmaceutical Chemistry and Drug Design

-
Image
Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bioactive sites. The drug is an active molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit. The main objective in drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it.   The us
Read more

Fundamentals of Drug Safety and Pharmacovigilance

-
Image
The challenge of maximizing drug safety and maintaining public confidence has become increasingly complex. Pharmaceutical and biotechnology companies must not only monitor, but also proactively assess and manage drug risk throughout a product’s lifecycle, from development to post market.   20th World Conference on Pharmaceutical Chemistry and Drug Design  is going to be held in Dubai during September 03-05 2018, under the enclosed title  "Pharmacovigilance" https://drug-chemistry.pharmaceuticalconferences.com/ Pharmacovigilance : WHO defined as 'the pharmacological science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’ An umbrella term used to describe the processes for monitoring and evaluating ADRs is a key component of effective drug regulation systems, clinical practice and public health programs. It is the study of the safety of marketed drugs examined unde
Read more